课题基金 / 基金详情

A patient self-assessment software combining compliance protocols to improve prescriber confidence, reduce liability, and improve patient outcomes.

A patient self-assessment software combining compliance protocols to improve prescriber confidence, reduce liability, and improve patient outcomes.
患者自我评估软件结合了依从性协议,可提高处方者的信心、减少责任并改善患者的治疗结果。
批准号:
10226096
负责人:
ABRAHAM G HARTZEMA
金额:
$93.41万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-08-01 至 2023-07-31

项目摘要

项目成果

ABRAHAM G HARTZEMA的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要 目前的过量流行是由阿片类药物的广泛非医疗使用助长的 开处方的大多是好心的医生,没有接受过适当的培训 启动、监测和停止阿片类药物治疗。许多患者开始使用慢性阿片类药物 治疗有一些因素使他们面临更高的物质滥用风险和可能的未来 然而,对于新患者来说,典型的初级保健就诊时间太短,无法进行彻底的评估。 这会使患者长期处于不符合标准的护理水平,从而使患者处于危险之中,并因缺乏足够的护理而使处方者面临风险 经证实的文件,以支持法律标准“合法医疗目的”。最新措施 旨在解决阿片类药物流行的最大障碍没有考虑到适当的患者护理和 好的法医文件,这就是时间。让事情更复杂的是,许多医生干脆拒绝 由于害怕刑事、民事或监管干预而开出阿片类药物。这使问题变得更加复杂 向开阿片类药物的诊所灌输新的、未经证实的患者,这些患者往往几乎用完了药物 或者已经戒掉了。这种常见的情况是导致芬太尼和其他合成药物的稳步上升 通过推动疼痛、依赖和成瘾患者寻求帮助导致阿片类药物过量死亡 非法手段。护理连续性计划(CCP)是Sure Med Compliance的产品,是一种新颖的在线患者 阿片类药物处方者使用自我评估来更好地确定患者风险因素和治疗益处。此工具 由患者在办公室外使用支持互联网的设备完成,并遵循 通过分析判例法在阿片类药物滥用案例中针对医生制定的驱动方案。结果,在 带有日期和时间戳的法律报告的形式会立即传输到处方人的电子健康 记录,减轻处方人的民事和刑事风险。调查结果的简要信息将显示在软件中 通过仪表板和报告摘要页。此软件产品包括移动设备和 标准的基于Web的应用程序。拟议研究的目标是验证协议和交付 通过测量患者结果、处方患者的信心和文档的完整性来建立CCP系统 在初级保健和疼痛管理环境中的患者图表中,显示实施CCP前后的情况。
英文摘要
PROJECT ABSTRACT The current overdose epidemic is being fueled by widespread, non-medical use of opioids prescribed by mostly well-meaning physicians with inadequate training on how to properly initiate, monitor and discontinue opioid therapy. Many patients being initiated on chronic opioid therapy have factors putting them at higher risk for substance misuse and possible future overdose, however the typical primary care visit for a new patient is too short for a thorough evaluation. This puts patients at risk by perpetuating a substandard level of care, and puts prescribers at risk by lacking substantiated documentation to support the legal standard “legitimate medical purpose”. Most current measures aimed at solving the opioid epidemic have not considered the biggest obstacle to appropriate patient care and good medicolegal documentation, which is time. To complicate the matter, many physicians are simply refusing to prescribe opioids for fear of criminal, civil or regulatory intervention. This is compounding the issue by inundating clinics that do prescribe opioids with new, unverified patients that are often almost out of medication or already in withdrawal. This common scenario is contributing to the steady rise of fentanyl and other synthetic opioid related overdose deaths by pushing patients with pain, dependence and addiction to seek help through illegal means. The Care Continuity Program (CCP), a product of Sure Med Compliance, is a novel, online patient self-assessment used by prescribers of opioids to better identify patient risk factors and therapy benefit. This tool is completed by the patient, outside of the office, using an internet enabled device and follows a compliance driven protocol developed by analyzing case law against physicians in mis-prescribing opioid cases. Results, in the form of a date and time stamped legal report, are instantly transmitted to the prescriber’s electronic health records, mitigating the prescriber’s civil and criminal risk. A brief of findings is displayed within the software through a dashboard and on the summary page of the report. This software offering includes a mobile and standard web-based application. The objective of the proposed research is to validate the protocols and delivery system of the CCP by measuring patient outcomes, prescriber confidence, and completeness of documentation in the patient chart in primary care and pain management settings, pre and post implementation of the CCP.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1007/s40264-022-01267-z
发表时间: 2023-03
期刊: DRUG SAFETY
影响因子: 4.2
作者: [Wang, Shuang, Meador, Kimford J., Pawasauskas, Jayne, Lewkowitz, Adam K., Ward, Kristina E., Brothers, Todd N., Hartzema, Abraham, Quilliam, Brian J., Wen, Xuerong]
通讯作者: Wen, Xuerong
A patient self-assessment software combining compliance protocols to improve prescriber confidence, reduce liability, and improve patient outcomes.
  • 批准号:
    10013399
  • 项目类别:
  • 资助金额:
    $72.23万
  • 财政年份:
    2020
  • 负责人:
    ABRAHAM G HARTZEMA
  • 依托单位:
HIT for Medication Safety in Critical Access Hospitals
  • 批准号:
    6890734
  • 项目类别:
  • 资助金额:
    $14.78万
  • 财政年份:
    2004
  • 负责人:
    ABRAHAM G HARTZEMA
  • 依托单位:
海外基金